Among the originally reported tumors with EGFR mutations, three were classified as fine bronchioloalveolar carcinomas, suggesting a higher prevalence of EGFR mutations in adenocarcinomas of the lung with features of fine bronchioloalveolar carcinoma.211. This evidence concerns the gene EGFR and bronchioloalveolar carcinoma.